Q6PL18 (ATAD2_HUMAN) Homo sapiens (Human)
ATPase family AAA domain-containing protein 2 UniProtKBInterProSTRINGInteractive Modelling
1390 aa; Sequence (Fasta) ; (Isoform 2)
It is possible new templates exist for this target since these models were created.
Available Structures
120 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Human ATAD2 Walker B mutant, ATP state |
Heteromer | 99.79 | 1×ADP; 5×ATP; | |||
| Human ATAD2 Walker B mutant-H3/H4K5Q complex, ATP state (Class II) |
Heteromer | 99.77 | 1×ADP; 5×ATP; | |||
| ATAD2 bromodomain complexed with histone H4K5ac (res 1-10) ligand |
Heteromer P62805; | 99.25 | ||||
| ATAD2 bromodomain in complex with H4S1phK5ac (res 1-15) ligand |
Heteromer P62805; | 99.25 | ||||
| ATAD2 bromodomain in complex with "oncohistone" mutation H4S1CK5ac (res 1-15) ligand |
Heteromer P62805; | 99.23 | ||||
| Structure of the bromodomain of human ATPase family AAA domain-containing protein 2 (ATAD2) complex… |
Heteromer P62805; | 100 | 1×SO4; 11×EDO; | |||
| Structure of the bromodomain of human ATPase family AAA domain-containing protein 2 (ATAD2) complex… |
Heteromer P62805; | 100 | 1×SO4; 9×EDO; | |||
| Human ATAD2 Walker B mutant-H3/H4K5Q complex, ATP state | homo-6-mer | 99.78 | 1×ADP; 5×ATP; | |||
| Human ATAD2 Walker B mutant-H3/H4K5Q complex, ATP state (Class III) | homo-6-mer | 99.78 | 1×ADP; 5×ATP; | |||
| Crystal structure of human ATAD2 bromodomain in complex with 5-5- methoxypyridin-3-yl-3-methyl-8-pi… | homo-2-mer | 100 | 4×EDO; 2×NP8; 6×SO4; | |||
| Crystal structure of human ATAD2 bromodomain in complex with 4-((3R, 4R)-4-3-methyl-5-(5-methylpyri… | homo-2-mer | 100 | 6×EDO; 2×YD3; 4×SO4; | |||
| Crystal structure of ATAD2A bromodomain complexed with H3(1-21)K14Ac peptide | homo-2-mer | 100 | 4×SO4; 2×CL; | |||
| XChem fragment screen -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF THE HUMAN ATAD2 in complex with N1… | monomer | 98.44 | 2×JMM; 2×SO4; 3×EDO; | |||
| ATAD2 in complex with PepLite-Val | monomer | 100 | 2×SO4; 1×CL; 1×IJ3; 2×EDO; | |||
| ATAD2 in complex with PepLite-Asp | monomer | 100 | 2×SO4; 1×CL; 4×EDO; 1×IIV; | |||
| ATAD2 in complex with FragLite3 | monomer | 100 | 2×SO4; 1×CL; 1×7ZX; 12×EDO; | |||
| ATPase family AAA domain containing 2 with crystallization epitope mutations V1022R:Q1027E | monomer | 98.44 | 2×EDO; | |||
| XChem fragment screen -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF THE HUMAN ATAD2 in complex with N1… | monomer | 98.44 | 1×K3D; 2×SO4; 4×EDO; | |||
| PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with TCJ732 | monomer | 98.44 | 1×RH4; 2×SO4; 4×EDO; | |||
| PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with DF826 | monomer | 98.44 | 3×RHG; 2×SO4; 3×EDO; | |||
| ATAD2 in complex with FragLite18 | monomer | 100 | 2×SO4; 1×CL; 8×EDO; 1×IJF; | |||
| ATAD2 in complex with PepLite-Glu | monomer | 100 | 2×SO4; 1×CL; 1×HNU; 2×EDO; | |||
| PanDDA analysis group deposition of ground-state model of ATAD2 | monomer | 98.44 | 2×SO4; 3×EDO; | |||
| ATAD2 in complex with FragLite23 | monomer | 100 | 2×SO4; 1×CL; 2×UU1; 6×EDO; | |||
| ATAD2 in complex with FragLite28 | monomer | 100 | 2×SO4; 1×CL; 8×EDO; 1×UUS; | |||
| PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with PC578 | monomer | 98.44 | 1×RGV; 2×SO4; 3×EDO; | |||
| XChem fragment screen -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF THE HUMAN ATAD2 in complex with N1… | monomer | 98.44 | 1×GWA; 2×SO4; 4×EDO; | |||
| ATAD2 in complex with FragLite1 | monomer | 100 | 2×SO4; 1×CL; 1×BYZ; 1×EDO; | |||
| PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with DF848 | monomer | 98.44 | 2×SO4; 4×EDO; 1×RH7; | |||
| XChem fragment screen -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF THE HUMAN ATAD2 in complex with N1… | monomer | 98.44 | 1×RWP; 2×SO4; 4×EDO; | |||
| ATAD2 in complex with PepLite-Tyr | monomer | 100 | 2×SO4; 1×CL; 4×EDO; 1×IK3; | |||
| ATAD2 in complex with FragLite33 | monomer | 100 | 2×SO4; 1×CL; 1×HWC; 6×EDO; | |||
| ATAD2 in complex with FragLite7 | monomer | 100 | 2×SO4; 1×CL; 2×HHQ; 5×EDO; | |||
| Crystal structure of the bromodomain of human ATAD2 in complex with Compound A12 | monomer | 100 | 1×5UE; 1×SO4; 1×CL; | |||
| ATAD2 in complex with FragLite2 | monomer | 100 | 2×SO4; 1×CL; 6×EDO; 1×PYZ; | |||
| ATAD2 in complex with FragLite6 | monomer | 100 | 2×SO4; 1×CL; 2×HGQ; 2×EDO; | |||
| PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with DF789 | monomer | 98.44 | 2×SO4; 6×EDO; 1×RHJ; | |||
| Crystal structure of the bromodomain of human ATAD2 in complex with Compound 49 | monomer | 100 | 2×5QW; 1×SO4; | |||
| ATAD2 in complex with PepLite-Arg | monomer | 100 | 2×SO4; 1×CL; 1×IJI; 6×EDO; | |||
| ATAD2 in complex with PepLite-Ala | monomer | 100 | 2×SO4; 1×CL; 2×EDO; 1×IJR; | |||
| ATAD2 in complex with FragLite10 | monomer | 100 | 2×SO4; 1×CL; 1×1P8; 2×EDO; | |||
| ATAD2 in complex with PepLite-Ile | monomer | 100 | 2×SO4; 1×CL; 2×EDO; 1×HQX; | |||
| PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with JKH93A | monomer | 98.44 | 1×RK7; 2×SO4; 3×EDO; | |||
| PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with TCJ779 | monomer | 98.44 | 1×RHV; 2×SO4; 3×EDO; | |||
| PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with JKH47 | monomer | 98.44 | 2×RJ7; 2×SO4; 3×EDO; | |||
| PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with DF776 | monomer | 98.44 | 1×RGD; 2×SO4; 3×EDO; | |||
| PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with RZ99 | monomer | 98.44 | 1×RK1; 2×SO4; 2×EDO; | |||
| The ATAD2 bromodomain in complex with compound 8 | monomer | 100.0 | 2×SO4; 3×G6E; | |||
| Crystal structure of the bromodomain of human ATAD2 in complex with Compound A14 | monomer | 100 | 1×SO4; 1×5U9; | |||
| Structure of the bromodomain of human ATPase family AAA domain-containing protein 2 (ATAD2) in comp… | monomer | 100 | 1×ALY; 2×SO4; 9×EDO; | |||
| PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with DF852 | monomer | 98.44 | 2×RJ4; 2×SO4; 2×EDO; | |||
| PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with DF853 | monomer | 98.44 | 2×SO4; 5×EDO; 1×RKG; | |||
| PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with PC587 | monomer | 98.44 | 1×RGY; 1×TQS; 2×SO4; 2×EDO; | |||
| The ATAD2 bromodomain in complex with compound 9 | monomer | 100.0 | 2×SO4; 2×G5Z; | |||
| The ATAD2 bromodomain in complex with compound 12 | monomer | 100 | 1×SO4; 1×G1E; 1×BQQ; | |||
| PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with RZ373 | monomer | 98.44 | 2×SO4; 5×EDO; 1×RJD; | |||
| The ATAD2 bromodomain in complex with compound 6 | monomer | 100 | 2×BOH; 1×SO4; | |||
| PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with DF849 | monomer | 98.44 | 1×RHY; 2×SO4; 3×EDO; | |||
| The ATAD2 bromodomain in complex with compound 7 | monomer | 100 | 1×G5W; 1×SO4; | |||
| Fragment-Based Screening of the Bromodomain of ATAD2 | monomer | 100 | 1×SO4; 1×TRS; 2×CL; 1×39R; | |||
| PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with PC581 | monomer | 98.44 | 1×RGM; 2×SO4; 4×EDO; | |||
| Crystal structure of ATAD2A bromodomain complexed with 3-(3,5-dimethyl-1,2-oxazol-4-yl)-5-[(phenyls… | monomer | 100 | 1×SO4; 2×GOL; 1×37N; 1×CL; 1×DMS; | |||
| PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with PC631 | monomer | 98.44 | 1×RJG; 2×SO4; 3×EDO; | |||
| The ATAD2 bromodomain in complex with compound 10 | monomer | 100 | 2×SO4; 1×G6B; | |||
| ATAD2 in complex with Acetyl-Lys | monomer | 100 | 1×ARG; 2×SO4; 1×CL; 5×EDO; 1×8WS; | |||
| The ATAD2 bromodomain in complex with compound 15 | monomer | 100 | 2×G7H; 1×SO4; | |||
| The ATAD2 bromodomain in complex with compound 16 | monomer | 100 | 1×SO4; 2×G7E; | |||
| PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with RZ189 | monomer | 98.44 | 2×SO4; 4×EDO; 1×RJJ; | |||
| The ATAD2 bromodomain in complex with compound 5 | monomer | 100 | 1×SO4; 1×BQT; | |||
| The ATAD2 bromodomain in complex with compound 2 | monomer | 100 | 1×SO4; 1×BQH; | |||
| Structure of the bromodomain of human ATPase family AAA domain-containing protein 2 (ATAD2) with bo… | monomer | 100 | 2×DMS; 1×SO4; 12×EDO; | |||
| Structure of the bromodomain of human ATPase family AAA domain-containing protein 2 (ATAD2) in comp… | monomer | 100 | 1×SO4; 5×EDO; 1×38T; | |||
| Crystal structure of ATAD2A bromodomain complexed with methyl 3-amino-5-(3,5-dimethyl-1,2-oxazol-4-… | monomer | 100 | 1×SO4; 1×CL; 1×GOL; 1×36Z; | |||
| Crystal structure of human ATAD2 bromodomain in complex with 8-(((3R,4R,5S)-3-((4,4-difluorocyclohe… | monomer | 100 | 4×EDO; 1×6XX; 1×SO4; | |||
| Crystal structure of human ATAD2 bromodomain in complex withN-(3-(azepan-1-ylsulfonyl)-4-methylphen… | monomer | 100 | 1×EDO; 1×KVT; 2×SO4; | |||
| PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with RZ201 | monomer | 98.44 | 1×RQP; 2×SO4; 1×EDO; | |||
| XChem fragment screen -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF THE HUMAN ATAD2 in complex with N1… | monomer | 98.44 | 1×GX4; 2×SO4; 4×EDO; | |||
| The ATAD2 bromodomain in complex with compound 3 | monomer | 100 | 2×BQW; 1×SO4; | |||
| Crystal structure of human ATAD2 bromodomain in complex with N-(4-bromo-3-(3-methylpyrrolidin-1-yl)… | monomer | 100 | 2×SO4; 3×EDO; 1×OJH; | |||
| Fragment-Based Screening of the Bromodomain of ATAD2 | monomer | 100 | 1×SO4; 4×CL; 1×39O; | |||
| Crystal structure of human ATAD2 bromodomain in complex with 4-(3R,4R) -4-(3-methyl-2-oxo-1,2-dihyd… | monomer | 100 | 3×EDO; 1×YEJ; 1×SO4; | |||
| PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with PC591 | monomer | 98.44 | 2×RKJ; 2×SO4; 2×EDO; | |||
| The ATAD2 bromodomain in complex with compound 13 | monomer | 100 | 1×G7N; 1×SO4; | |||
| Structure of the bromodomain of human ATPase family AAA domain-containing protein 2 (ATAD2) in comp… | monomer | 100 | 1×SO4; 8×EDO; 1×THM; | |||
| Structure of the bromodomain of human ATPase family AAA domain-containing protein 2 (ATAD2) in comp… | monomer | 100 | 2×SO4; 7×EDO; 1×TDR; | |||
| The ATAD2 bromodomain in complex with compound 11 | monomer | 100 | 1×SO4; 1×G6W; | |||
| ATAD2 in complex with PepLite-Gly | monomer | 100 | 2×SO4; 1×CL; 1×IIY; 5×EDO; | |||
| Crystal structure of human ATAD2 bromodomain in complex with 3-methyl-8-((8-methyl-8-azabicycloocta… | monomer | 100 | 3×SO4; 2×EDO; 1×FZB; | |||
| The ATAD2 bromodomain in complex with compound UZH-DU32 | monomer | 100 | 2×BQ8; 1×SO4; | |||
| Crystal structure of the bromodomain of human ATAD2 with a disulfide bridge | monomer | 100 | 2×SO4; 1×EPE; | |||
| Structure of the bromodomain of human ATPase family AAA domain-containing protein 2 (ATAD2) in comp… | monomer | 100 | 1×SO4; 5×EDO; 1×38S; | |||
| ATAD2 in complex with FragLite29 | monomer | 100 | 2×SO4; 1×CL; 7×EDO; 1×V3U; | |||
| Crystal structure of human ATAD2 bromodomain in complex with (2S)-2,6- diacetamido-N-methylhexanami… | monomer | 100 | 2×EDO; 1×8WS; 2×SO4; | |||
| Crystal structure of the bromodomain of ATAD2 with phenol HTS hit (cpd 6) | monomer | 100 | 3×SO4; 1×963; | |||
| Crystal structure of the bromodomain of the human ATAD2 | monomer | 100 | 2×SO4; 1×CL; | |||
| Crystal structure of the bromodomain of ATAD2 with triazolopyridine (cpd 14) | monomer | 100 | 3×SO4; 1×95O; | |||
| Crystal structure of the bromodomain of ATAD2 with triazolopyridazine (cpd 22) | monomer | 100 | 3×SO4; 1×93L; | |||
| Crystal structure of human ATAD2 bromodomain in complex with 3-methyl- 8-piperidin-4-ylamino-1,2-di… | monomer | 100 | 2×EDO; 1×6XC; 2×SO4; | |||
| Structure of the bromodomain of human ATPase family AAA domain-containing protein 2 (ATAD2) with bo… | monomer | 100 | 2×SO4; 3×MPD; 1×GOL; | |||
| Structure of the bromodomain of human ATPase family AAA domain-containing protein 2 (ATAD2) in comp… | monomer | 100 | 2×SO4; 3×MPD; 1×GOL; 1×MB3; | |||
| Crystal structure of ATAD2A bromodomain double mutant N1063A-Y1064A in apo form | monomer | 98.44 | 1×SO4; 1×CL; 1×GOL; | |||
| Crystal structure of human ATAD2 bromodomain in complex with N-(4-chloro-3-(N,N-dimethylsulfamoyl)p… | monomer | 100 | 2×EDO; 2×SO4; 1×KVZ; | |||
| The ATAD2 bromodomain in complex with compound 14 | monomer | 100 | 1×G6Z; 1×SO4; | |||
| Crystal structure of human ATAD2 bromodomain in complex with 8-(3R,4R) -3-(cyclohexylmethoxy)piperi… | monomer | 100 | 2×EDO; 1×78J; 2×SO4; | |||
| Crystal structure of human ATAD2 bromodomain in complex with 8-2-(dimethylamino)ethylamino-3-methyl… | monomer | 100 | 2×EDO; 1×JTF; 1×SO4; | |||
| Crystal structure of human ATAD2 bromodomain in complex with 3-methyl- 1,2-dihydroquinolin-2-one | monomer | 100 | 3×EDO; 1×J5I; 1×SO4; | |||
| Structure of the bromodomain of human ATPase family AAA domain-containing protein 2 (ATAD2) in comp… | monomer | 100 | 1×12Q; 2×SO4; 15×EDO; | |||
| Crystal structure of the bromodomain of ATAD2 with AZ13824374 | monomer | 100 | 2×SO4; 1×96L; | |||
| The ATAD2 bromodomain in complex with compound 17 | monomer | 100 | 1×G7Q; 1×SO4; | |||
| The ATAD2 bromodomain in complex with compound UZH-DS15 | monomer | 100 | 1×BQE; 1×SO4; | |||
| The ATAD2 bromodomain in complex with compound UZH-DQ41 | monomer | 100 | 1×BQK; 1×SO4; | |||
| Crystal structure of human ATAD2 bromodomain in complex with N-(4-bromo-3-((3-methylpiperidin-1-yl)… | monomer | 100 | 2×EDO; 2×SO4; 1×KW5; | |||
| ATAD2 in complex with FragLite16 | monomer | 100 | 2×SO4; 1×CL; 4×EDO; 1×HH8; | |||
| Structure of human ATAD2 bromodomain bound to fragment inhibitor | monomer | 100 | 2×SO4; 1×CL; 1×39U; | |||
| ATAD2 in complex with 1-Methyl-2-quinolone | monomer | 100 | 1×12Q; 1×SO4; 3×EDO; | |||
| Crystal structure of apo ATAD2A bromodomain with N1064 alternate conformation | monomer | 100 | 1×SO4; | |||
| Crystal structure of ATAD2A bromodomain complexed with H4(1-20)K5Ac peptide | monomer | 100 | ||||
| ATAD2 in complex with FragLite31 | monomer | 100 | 2×SO4; 1×CL; 2×EDO; 2×HHT; | |||
| Crystal structure of human ATAD2 bromodomain in complex with 8-(((1R,2R,3R,5S)-2-(2-(1,1-dioxidotet… | monomer | 100 | 2×EDO; 1×FZH; 2×SO4; | |||
| The ATAD2 bromodomain in complex with compound 4 | monomer | 100 | 1×G7B; 1×SO4; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8h3h.1.A | homo-6-mer | 0.50 | 1×ADP; | 93.50 | ||
1 SWISS-MODEL model built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 8h3h.1.A | homo-6-mer | 0.64 | 99.32 | |||